Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin IV vs Oral in Healthy Adults
NCT07323680Phase 1Completed
- Sponsor
- Rhoshan Pharmaceuticals
- Start
- Jun 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of aspirin (2 arms), sponsored by Rhoshan Pharmaceuticals. Primary endpoint: Change in serum thromboxane B2 from baseline at 180 months. Started Jun 2025; status: completed.
02
Drugs
aspirin
Beyond the preview
Go deeper on NCT07323680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07323680.